Neonatal End-of-Life Symptom Management

Purpose of review: Despite advances in technology and treatment options, over 15,000 neonates die each year in the United States. The majority of the deaths, with some estimates as high as 80%, are the result of a planned redirection of care or comfort measures only approach to care. When curative o...

Full description

Bibliographic Details
Main Authors: DonnaMaria E. Cortezzo, Mark Meyer
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fped.2020.574121/full
_version_ 1830410916745707520
author DonnaMaria E. Cortezzo
DonnaMaria E. Cortezzo
DonnaMaria E. Cortezzo
DonnaMaria E. Cortezzo
Mark Meyer
Mark Meyer
Mark Meyer
Mark Meyer
author_facet DonnaMaria E. Cortezzo
DonnaMaria E. Cortezzo
DonnaMaria E. Cortezzo
DonnaMaria E. Cortezzo
Mark Meyer
Mark Meyer
Mark Meyer
Mark Meyer
author_sort DonnaMaria E. Cortezzo
collection DOAJ
description Purpose of review: Despite advances in technology and treatment options, over 15,000 neonates die each year in the United States. The majority of the deaths, with some estimates as high as 80%, are the result of a planned redirection of care or comfort measures only approach to care. When curative or life-prolonging interventions are not available or have been exhausted, parents focus on preserving quality of life and eliminating needless suffering. Parents hope their child will have a peaceful death and will not feel pain. A significant component of end-of-life care is high quality symptom evaluation and management. It is important that neonatal providers are knowledgeable in symptom management to address common sources of suffering and distress for babies and their families at the end-of-life (EOL).Recent findings: Medically complex neonates with life-threatening conditions are a unique patient population and there is little research on end-of-life symptom assessment and management. While there are tools available to assess symptoms for adolescents and adults, there is not a recognized set of tools for the neonatal population. Nonetheless, it is widely accepted that neonates experience significant symptoms at end-of-life. Most commonly acknowledged manifestations are pain, dyspnea, agitation, and secretions. In the absence of data and established guidelines, there is variability in their clinical management. This contributes to provider discomfort and inadequate symptom control.Summary: End-of-life symptom assessment and management is an important component of neonatal end-of-life care. While there remains a paucity of studies and data, it is prudent that providers adequately manage symptoms. Likewise, it is important that providers are educated so that they can effectively guide families through the dying process by discussing disease progression, physical changes, and providing empathetic support. In this review, the authors make recommendations for non-pharmacological and pharmacological management of end-of-life symptoms in neonates.
first_indexed 2024-12-20T19:38:35Z
format Article
id doaj.art-94a0acbae315439db44fccd9bdc3c8fd
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-12-20T19:38:35Z
publishDate 2020-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-94a0acbae315439db44fccd9bdc3c8fd2022-12-21T19:28:35ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602020-09-01810.3389/fped.2020.574121574121Neonatal End-of-Life Symptom ManagementDonnaMaria E. Cortezzo0DonnaMaria E. Cortezzo1DonnaMaria E. Cortezzo2DonnaMaria E. Cortezzo3Mark Meyer4Mark Meyer5Mark Meyer6Mark Meyer7Division of Neonatal and Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United StatesDivision of Pain and Palliative Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United StatesDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United StatesDepartment of Anesthesiology, University of Cincinnati College of Medicine, Cincinnati, OH, United StatesDivision of Pain and Palliative Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United StatesDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United StatesDepartment of Anesthesiology, University of Cincinnati College of Medicine, Cincinnati, OH, United StatesDivision of Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United StatesPurpose of review: Despite advances in technology and treatment options, over 15,000 neonates die each year in the United States. The majority of the deaths, with some estimates as high as 80%, are the result of a planned redirection of care or comfort measures only approach to care. When curative or life-prolonging interventions are not available or have been exhausted, parents focus on preserving quality of life and eliminating needless suffering. Parents hope their child will have a peaceful death and will not feel pain. A significant component of end-of-life care is high quality symptom evaluation and management. It is important that neonatal providers are knowledgeable in symptom management to address common sources of suffering and distress for babies and their families at the end-of-life (EOL).Recent findings: Medically complex neonates with life-threatening conditions are a unique patient population and there is little research on end-of-life symptom assessment and management. While there are tools available to assess symptoms for adolescents and adults, there is not a recognized set of tools for the neonatal population. Nonetheless, it is widely accepted that neonates experience significant symptoms at end-of-life. Most commonly acknowledged manifestations are pain, dyspnea, agitation, and secretions. In the absence of data and established guidelines, there is variability in their clinical management. This contributes to provider discomfort and inadequate symptom control.Summary: End-of-life symptom assessment and management is an important component of neonatal end-of-life care. While there remains a paucity of studies and data, it is prudent that providers adequately manage symptoms. Likewise, it is important that providers are educated so that they can effectively guide families through the dying process by discussing disease progression, physical changes, and providing empathetic support. In this review, the authors make recommendations for non-pharmacological and pharmacological management of end-of-life symptoms in neonates.https://www.frontiersin.org/article/10.3389/fped.2020.574121/fullPerinatal palliative careneonatalend-of-lifesymptom managementpharmacological management
spellingShingle DonnaMaria E. Cortezzo
DonnaMaria E. Cortezzo
DonnaMaria E. Cortezzo
DonnaMaria E. Cortezzo
Mark Meyer
Mark Meyer
Mark Meyer
Mark Meyer
Neonatal End-of-Life Symptom Management
Frontiers in Pediatrics
Perinatal palliative care
neonatal
end-of-life
symptom management
pharmacological management
title Neonatal End-of-Life Symptom Management
title_full Neonatal End-of-Life Symptom Management
title_fullStr Neonatal End-of-Life Symptom Management
title_full_unstemmed Neonatal End-of-Life Symptom Management
title_short Neonatal End-of-Life Symptom Management
title_sort neonatal end of life symptom management
topic Perinatal palliative care
neonatal
end-of-life
symptom management
pharmacological management
url https://www.frontiersin.org/article/10.3389/fped.2020.574121/full
work_keys_str_mv AT donnamariaecortezzo neonatalendoflifesymptommanagement
AT donnamariaecortezzo neonatalendoflifesymptommanagement
AT donnamariaecortezzo neonatalendoflifesymptommanagement
AT donnamariaecortezzo neonatalendoflifesymptommanagement
AT markmeyer neonatalendoflifesymptommanagement
AT markmeyer neonatalendoflifesymptommanagement
AT markmeyer neonatalendoflifesymptommanagement
AT markmeyer neonatalendoflifesymptommanagement